Get notified when KEQU files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: KEQU KEWAUNEE SCIENTIFIC CORP /DE/ 10-K

KEQU sales +17% on Nu Aire, but backlog falls 23% and net earnings drop 16%

Filed June 26, 2026 · Period ending April 30, 2026 · Compared to 10-K Jul 2, 2025 · ~1 min read

Key Changes

  • high

    Order backlog declined 23% year-over-year to $165.9M (from $214.6M), reversing prior-year growth and signaling weaker forward order flow despite Nu Aire acquisition.

    Business: Order backlog decline verify on EDGAR →
  • high

    Net earnings fell 16% to $9.6M ($3.22/share) despite 17% sales growth, as operating expenses rose 25% and interest expense increased 20% from acquisition debt.

    MD&A: Net earnings decline verify on EDGAR →
  • high

    Company repaid $23M seller note early (Dec 2025) and drew additional $10M on PNC term loan to fund the payoff, reducing total debt obligations to $69.6M from $90.7M.

    Notes: Seller note repayment verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ATLN 10-Q) is open in full — no account needed.

Partner

Trade KEQU commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.